Skin-interfaced biosensors for advanced wireless physiological monitoring in neonatal and pediatric intensive-care units.
Ha Uk Chung, Alina Y Rwei, Aurélie Hourlier-Fargette...
https://pubmed.ncbi.nlm.nih.gov/32161411Actively Recruiting
Led by Ann & Robert H Lurie Children's Hospital of Chicago · Updated on 2024-11-27
500
Participants Needed
2
Research Sites
25 weeks
Total Duration
Researchers are evaluating biocompatible wireless electronic devices designed to continuously and non-invasively measure vital signs and physiological data in patients within the Intensive Care Unit (ICU) and in non-ICU pediatric populations. This observational study aims to compare data from these novel wearable sensors with standard monitoring devices to improve patient care in critical settings, particularly focusing on children under 18 years of age. The study is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago and includes patients from multiple ICUs and healthy volunteers who visit a pediatric autonomic medicine center. The study involves placing up to five wireless wearable vital sign monitors on ICU patients for up to 48 hours, attached to various body locations such as the chest, back, or limbs using medical-grade adhesives or hypoallergenic soft wrap-around devices. For non-ICU participants, these sensors are worn for up to three hours during a single outpatient visit. The devices continuously capture data including blood pressure, respiratory rate using bioimpedance, and skin temperature, while standard cuff-based blood pressure and skin temperature measurements are also recorded for comparison. Optional video monitoring of participant movement and position may be conducted with family consent. Participants undergo screening through medical record reviews or parent/guardian interviews depending on ICU or non-ICU status. Skin integrity is closely monitored before, during, and after sensor use using validated scales and photographs. Data from wearable sensors and standard monitoring systems are securely collected and stored for analysis. After the monitoring period, parents complete brief questionnaires about the devices. The primary outcome measures focus on continuous non-invasive blood pressure monitoring for up to 48 hours, with secondary outcomes assessing the accuracy of other physiological signals.
CONDITIONS
Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit
Duration - Up to 48 hours for ICU participants; up to 3 hours for non-ICU participants
Participants have up to 5 wearable vital sign sensors placed on various body locations to continuously monitor vital signs. In ICU patients, devices are worn for up to 48 hours with checks at least every 24 hours to ensure skin integrity and signal quality. In non-ICU participants, sensors are worn for up to 3 hours during a single outpatient study visit. Standard care monitoring continues alongside wearable sensors.
1 to 2 visits depending on participant group
Duration - Up to 48 hours for ICU participants; up to 3 hours for non-ICU participants
Data from wearable sensors and standard care monitors are collected and compared. Skin integrity is assessed before and after device use, with additional assessments as needed. Optional video monitoring of participant movement and position may be performed during the study period.
Monitoring during device wear period; no additional visits
Duration - Single follow-up after device monitoring
Parents or guardians complete questionnaires to provide feedback on device use in the ICU. These questionnaires take less than 10 minutes and are completed after the study period ends.
1 follow-up visit or remote completion
Total: 2 locations
1
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611
Actively Recruiting
2
Northwestern Medicine Prentice Women's Hospital
Chicago, Illinois, United States, 60611
Actively Recruiting
S
Susan Slattery, MD
C
Casey Rand, MDS
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ha Uk Chung, Alina Y Rwei, Aurélie Hourlier-Fargette...
https://pubmed.ncbi.nlm.nih.gov/32161411Ha Uk Chung, Bong Hoon Kim, Jong Yoon Lee...
https://pubmed.ncbi.nlm.nih.gov/30819934